Melanie Carreon, M.D , offers Ozempic Shot for weight loss at LCS Med Spa
A topical study cannot establish the efficacy or safety of subcutaneous injection
When considering adjunctive pharmacotherapy for weight management in patients with Hashimoto's disease, several principles apply
Tirzepatide is a novel agent that acts as an agonist for both GLP-1 receptors and gastric inhibitory polypeptide (GIP) receptors, another incretin that lowers glucose and appetite
CTSI's external affairs manager Kerry Nicol said, These are not harmless beauty treatments they are medicalstyle procedures being administered with no clinical oversight the consequences can be devastating. Richard Knight, CTSI lead officer for cosmetics and beauty, highlighted enforcement barriers, adding,Our current product and service provision laws dont adequately regulate this emerging area